Literature DB >> 26588329

Ventriculostomy and Lytic Therapy for Intracerebral Hemorrhage.

Wendy C Ziai, Paul A Nyquist, Daniel F Hanley.   

Abstract

Intraventricular hemorrhage (IVH) frequently complicates intracranial hemorrhage (ICH) and is a significant independent contributor to morbidity and mortality, yet therapy directed at ameliorating intraventricular clotting has been limited and until recently, has not been subject to systematic evaluation. Thrombolytic therapy with placement of an external ventricular drain for management of severe IVH secondary to ICH has been investigated in multiple observational studies, small randomized controlled trials and several meta-analyses, soon to culminate with the completion of the 500 patient CLEAR IVH randomized controlled trial. We review conventional and lytic therapeutic approaches to severe IVH in the setting of small ICH, articulating the scope of the problem, management issues, and relevant questions for future research.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26588329     DOI: 10.1159/000437118

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  1 in total

1.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.

Authors:  Santosh B Murthy; Issam Awad; Sagi Harnof; Francois Aldrich; Mark Harrigan; Jack Jallo; Jean-Louis Caron; Judy Huang; Paul Camarata; Lucia Rivera Lara; Rachel Dlugash; Nichol McBee; Vahid Eslami; Daniel F Hanley; Wendy C Ziai
Journal:  Neurology       Date:  2017-06-28       Impact factor: 9.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.